• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Now what, Zytiga has some real competition with Xtandi..

Quote












I don't sell Zytiga or Xtandi but I know the difference between the two.


Let me ask you this, if you were in a gun fight, would you rather have a better bullet proof vest or fewer bullets shot at you?

Figure that one out!
 








Well, I would prefer fewer bullets because not every bullet is going to be a direct hit. but you are correct in that Xtandi prevents/blocks androgen from feeding the tumor when Zytiga reduces, prevents the production of androgens. I think that both meds should be administered together.
 




Anonymous said:
I can't close the sale in Urology...all of my urology docs are waiting on xtandi. Are we cooked?
Click to expand...

BS! looks like someone is motivated to stir up a conversation and mine for competitive messaging. Are we going to fall for it so they can fill in the blanks on their monthly monitoring report for the competition? or should we feed them the BS they deserve?
 




Top Bottom
Back
Quote